Changing the Way Medicine Works
Aurinia is a clinical-stage pharmaceutical company focused on the global nephrology and autoimmunity markets. We are currently developing a novel Phase 2b lupus nephritis (LN) therapy, Voclosporin, a calcineurin-inhibitor (CNI) and NCE with specific advantages over existing therapies. Our team is focused on making life better for those suffering from debilitating diseases like LN.
Contact us for more information on careers with Aurinia.
There are currently no open positions. Please check back soon for new opportunities.